The association of epidermal growth factor variant with oral squamous cell carcinoma

Environ Mol Mutagen. 2023 Oct-Nov;64(8-9):473-479. doi: 10.1002/em.22572. Epub 2023 Sep 19.

Abstract

In this study, our aim was to investigate the epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) gene polymorphisms in oral squamous cell carcinoma (OSCC) patients and non-OSCC healthy controls. This case-control study comprised 89 OSCC and 107 healthy controls by using polymerase chain reaction (PCR) and restriction fragment length polymorphism methods, the genotypes for EGF + 61 A > G (rs4444903) and EGFR R497K (rs2227983) were analyzed. According to the EGF + 61 A > G genotype distribution, individuals with the GG genotype were more prevalent in the OSCC group when compared to the healthy controls. But the AA genotype frequency was significantly higher in the healthy control group. The frequency of G allele carriers was 2.3 times higher than A allele carriers in OSCC patients (p < .001). For the EGFR R497K genotype, there was no significant difference between the OSCC and healthy control groups. Regarding the study results, the G allele of EGF + 61 A > G polymorphism was associated with OSCC. Larger populations and functional investigations should be used to explore the nature of the interaction between EGF and OSCC.

Keywords: EGFR R497KK; EGF + 61A > G; epidermal growth factor; genetic polymorphism; oral squamous cell carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Epidermal Growth Factor / genetics
  • ErbB Receptors
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Head and Neck Neoplasms*
  • Humans
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / pathology
  • Squamous Cell Carcinoma of Head and Neck* / genetics

Substances

  • Epidermal Growth Factor
  • EGFR protein, human
  • ErbB Receptors